2015
DOI: 10.1016/j.jconrel.2015.06.020
|View full text |Cite
|
Sign up to set email alerts
|

A fusogenic peptide from a sea urchin fertilization protein promotes intracellular delivery of biomacromolecules by facilitating endosomal escape

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
16
0

Year Published

2015
2015
2025
2025

Publication Types

Select...
5
2

Relationship

1
6

Authors

Journals

citations
Cited by 22 publications
(16 citation statements)
references
References 36 publications
0
16
0
Order By: Relevance
“…The advantage of FP-fused antibodies over FP-fused eGFP is that allows target cell-specific intracellular delivery of various biomacromolecules. However, their activities of these fusion antibodies were somewhat low compared with that of FP-fused eGFP (21). One reason for this disadvantage may be that most of antibodies remain bound to antigens after internalization by endocytosis, likely reducing the endosomal escape efficiency.…”
Section: Discussionmentioning
confidence: 99%
See 3 more Smart Citations
“…The advantage of FP-fused antibodies over FP-fused eGFP is that allows target cell-specific intracellular delivery of various biomacromolecules. However, their activities of these fusion antibodies were somewhat low compared with that of FP-fused eGFP (21). One reason for this disadvantage may be that most of antibodies remain bound to antigens after internalization by endocytosis, likely reducing the endosomal escape efficiency.…”
Section: Discussionmentioning
confidence: 99%
“…1A). The B18 and B55 peptides are FPs that facilitated the endosomal escape of cargo proteins in HeLa cells as shown in our previous study (21). The TAT, a CPP derived from the HIV-1 virus, were also used to compare the functions of the FPs with a CPP.…”
Section: Preparation Of Fp-fused Scfv Proteins and Confirmation Of Thmentioning
confidence: 93%
See 2 more Smart Citations
“…Endosome is the main bottleneck in intracellular gene delivery path. During the last few decades, several de novo designed or biologically derived endosomal release peptides have been reported 30 37 53 54 . However, the complicated mechanisms underlying endosome release and the inability of these peptides to show their actual activities, makes it more difficult to have a preference for selecting the most efficient and the most effective ones.…”
Section: Discussionmentioning
confidence: 99%